ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI advisors seek comment on clinical trials system, until Jan. 15.

December 10, 2004

Senate Subcommittee Gives NCI 41.397 Billion for FY ‘87

August 8, 1986

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

Clinical Trials Approved In August 2002 By NCI

September 27, 2002

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002